麗豐-KY

-1.10 (-1.44%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

75.20154成交張數11.14本益比1.26股價淨值比13.30%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	100	49	50.7%	1.64	59.84	11.9%	6.1%	1.3	1.1
2026Q1	98	56	43.2%	2.07	67.60	11.5%	6.9%	0.5	0.5
2025Q4	95	53	44.6%	1.86	63.97	10.9%	6.4%	1.6	1.3
2025Q3	91	48	46.9%	1.60	58.50	9.6%	5.5%	3.5	3.4
2025Q2	82	44	46.5%	2.20	53.44	9.4%	5.1%	4.4	3.3
2025Q1	89	57	35.8%	3.24	69.43	8.2%	5.1%	-1.8	-2.4
2024Q4	89	55	37.7%	2.98	67.21	8.8%	5.3%	3.0	2.6
2024Q3	88	55	37.2%	3.10	66.87	13.5%	7.7%	1.0	0.7
2024Q2	95	53	44.6%	1.70	63.66	15.5%	8.2%	1.6	-2.6
2024Q1	91	54	41.2%	1.94	67.56	13.6%	7.8%	0.2	0.1
2023Q4	89	51	42.2%	1.87	64.77	21.1%	11.8%	1.5	-0.4
2023Q3	98	51	48.4%	1.99	63.81	19.1%	10.0%	4.3	4.0
2023Q2	91	47	49.1%	2.26	58.57	19.7%	10.1%	3.7	3.4
2023Q1	91	51	44.3%	2.77	63.53	14.8%	8.3%	2.9	2.8
2022Q4	86	47	45.9%	3.28	58.51	14.3%	7.4%	0.8	0.6
2022Q3	89	47	47.1%	3.13	59.45	17.6%	8.9%	1.8	1.7
2022Q2	88	45	48.5%	2.11	56.83	22.4%	11.7%	1.4	1.3
2022Q1	98	55	43.5%	2.52	69.61	26.4%	14.2%	-1.2	-1.4
2021Q4	100	50	50.2%	2.21	62.81	28.8%	14.3%	7.5	7.2
2021Q3	96	46	51.7%	2.04	58.20	31.2%	14.6%	5.2	4.8
2021Q2	92	49	46.5%	2.08	62.09	29.7%	14.6%	1.5	1.3
2021Q1	92	47	49.5%	1.93	58.76	25.9%	13.6%	3.9	3.8
2020Q4	90	44	50.8%	2.10	55.46	21.8%	11.2%	9.6	9.2
2020Q3	87	40	54.8%	1.95	49.76	25.3%	12.2%	5.2	5.0
2020Q2	80	35	56.2%	1.50	44.11	28.6%	13.7%	1.3	1.2
2020Q1	80	44	45.1%	1.95	55.15	25.6%	15.1%	-0.9	-1.1
2019Q4	82	44	46.3%	1.91	55.12	33.7%	19.7%	5.4	4.7
2019Q3	79	41	48.1%	1.68	51.23	35.1%	19.3%	5.1	4.1
2019Q2	75	39	47.9%	1.67	49.35	36.1%	19.7%	3.5	3.4
2019Q1	72	46	36.3%	2.19	57.85	30.2%	19.6%	4.4	4.2
2018Q4	64	41	35.6%	2.12	51.75	32.1%	20.7%	4.2	4.1
2018Q3	64	38	41.5%	1.96	47.30	30.6%	18.7%	2.9	-2.0
2018Q2	61	35	42.3%	1.79	44.30	27.7%	15.9%	2.2	1.9
2018Q1	59	39	33.9%	2.35	49.24	21.9%	14.3%	3.8	3.5
2017Q4	54	35	35.4%	2.21	43.80	16.6%	10.6%	5.1	5.0
2017Q3	51	33	35.4%	2.17	41.48	15.4%	10.1%	1.8	1.7
2017Q2	54	31	42.8%	1.85	39.21	15.3%	8.8%	1.2	1.1
2017Q1	53	34	35.1%	2.25	42.96	13.1%	8.8%	-1.0	-1.3
2016Q4	56	36	36.5%	2.10	44.78	–	–	3.6	3.4
2016Q3	53	35	33.3%	4.43	44.26	–	–	2.3	2.0